National Review
The White House press secretary shies away when asked why Hunter Biden still has a stake in a Chinese investment firm
White House press secretary Jen Psaki questioned on Friday why President Biden’s son Hunter Biden still has an investment in a Chinese company. Asked during a press conference at the White House whether she had an update on Hunter Biden’s divestment of his 10 percent stake in Chinese private equity firm BHR Partners, Psaki referred a reporter to the young Biden’s lawyers. “He has been working to undo his investment,” said Psaki, adding: “As a citizen, I would like to tell you or your outside lawyers about any updates.” In December, Biden assured voters that he and his family would not be involved in business that appeared to conflict with the office of president. “My son, my family will not be involved in any business, any company that is in conflict or appears to be in conflict with the appropriate distance from the presidency and the government,” said Biden during an appearance on CNN. Hunter Biden was reportedly in the process of divesting his stake in BHR at the end of December, but last week, he appears to have maintained his investment through his company, Skaneateles LLC. BHR, whose largest shareholder is the Bank of China, controlled by the Chinese government, invested about US $ 2.1 billion. Hunter Biden was investigated last year for his lucrative position on the board of Ukrainian natural gas company Burisma. In leaked emails from 2014, Biden seems to be trying to leverage his influence with his father, then Vice President Joe Biden, who was heavily involved in US policy towards Ukraine, referring to the older Biden as “my man” “. He also drew criticism for having signed a consultancy contract with China’s largest private energy company, which initially earned Hunter Biden $ 10 million a year “just for launches,” according to leaked emails. Hunter Biden’s memoir, “Beautiful Things”, is scheduled to come out on April 6. The book will focus on young Biden’s well-documented drug abuse issues, according to Gallery Books, a Simon & Schuster brand.